SynthesisFrontiers in immunology2020

Emerging Blood-Based Biomarkers for Predicting Response to Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer.

Shumin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.